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Abstract 53 
Emerging data show that tissue-resident memory T cells (TRM) play an important protective role at 54 
murine and human barrier sites. Mouse skin-TRM cells in the epidermis patrol their surroundings and 55 
rapidly respond upon antigen encounter. However, whether a similar migratory behavior is performed 56 
by human TRM cells is unclear, as technology to longitudinally follow them in situ has been lacking. To 57 
address this issue, we developed an ex vivo culture system to label and track T cells in fresh skin 58 
samples. We validated this system by comparing in vivo and ex vivo properties of murine TRM
 cells. 59 
Using nanobody labeling, we subsequently demonstrate in human ex vivo skin that CD8+ TRM cells 60 
migrated through the papillary dermis and the epidermis, below sessile Langerhans cells. Collectively, 61 
this work allows the dynamic study of resident immune cells in human skin and demonstrates the 62 
existence of tissue patrol by human CD8+ TRM cells.  63 
64 
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Introduction 65 
Tissue-resident memory T cells (TRM) are non-circulating lymphocytes that play a key role in peripheral 66 
immunity. TRM cells have been described in both mouse and human tissues such as lung, intestine, 67 
brain and skin1, 2, 3, 4 and show a transcriptional profile that is, among others, characterized by CD69 68 
expression and in some tissues also CD103 expression5, 6, 7. The TRM cells that reside at peripheral 69 
sites orchestrate immune responses against pathogens, but also contribute to autoimmune and 70 
allergic disorders4, 8, 9, 10. Furthermore, CD103+ T cells are present in human cancer lesions such as 71 
melanoma11, ovarian12 and lung cancer13, 14, are enriched in tumor reactivity15 and are therefore 72 
thought to play a central role in tumor control.  73 
Intravital imaging studies in mouse models have demonstrated that CD8+ TRM cells in skin 74 
tissue actively crawl in between keratinocytes in search of newly infected cells, a property termed 75 
tissue patrol16, 17. Encounter of antigen-expressing cells by TRM cells in mouse models is accompanied 76 
by a reduction in their motility and dendricity, as revealed by in vivo imaging16, 18, 19. Furthermore, 77 
antigen encounter by CD8+ TRM cells induces the tissue-wide expression of interferon-γ (IFN-γ) 78 
responsive genes, as for instance demonstrated by transcriptional analyses20, 21.  79 
While there is a growing appreciation of the relevance of human skin-resident TRM cells in 80 
health and disease4, 22, the in situ behavior of these cells has not been analyzed. To address this 81 
issue, we set out to develop an ex vivo tissue culture system to study the dynamic behavior of TRM 82 
cells in fresh skin biopsies. We first validated this system on mouse tissue by comparison of in vivo 83 
and ex vivo TRM cell migration and antigen recognition by ex vivo TRM cells. We subsequently 84 
determined how TRM cells in fresh biopsy material can be visualized by staining with fluorescent anti-85 
CD8 nanobodies, without impairing their ability to respond to antigen encounter. We then applied this 86 
approach to healthy human skin samples and demonstrate that human CD8+ skin-resident TRM cells 87 
migrated in both the epidermal and dermal compartment. In the epidermal compartment, CD8+ TRM 88 
cells moved along the stratum basale, in close proximity to the basement membrane, and below a pool 89 
of stationary Langerhans cells. In the papillary dermis, migration of CD8+ TRM cells in both collagen 90 
type I-dense regions and in collagen type I-poor areas along dermal vessels was observed. This study 91 
demonstrates that tissue patrol is a property of human tissue-resident memory CD8+ T cells and 92 
provides a platform to study the real-time behavior of these cells in situ.  93 
94 
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Results  95 
Ex vivo migration of murine CD8+ TRM cells in skin tissue  96 
In order to study human skin-resident TRM cell behavior in real-time, we aimed to set up a skin culture 97 
system suitable for live-cell imaging. To this end, we explored an ex vivo culture system previously 98 
used to image melanoblast migration23 to investigate whether TRM cell behavior in such an ex vivo 99 
system recapitulates in vivo cell behavior. In this setup, a fresh skin biopsy is mounted between a gas-100 
permeable membrane at the epidermal side and a filter covered by matrigel and medium on the 101 
dermal side (Fig. 1a). This system ensures gas exchange at the exterior side of the skin, while 102 
providing diffusion of nutrients on the interior side.  103 
To examine whether such an ex vivo imaging system can be used to reliably describe 104 
properties of skin-resident TRM cells, we first compared ex vivo TRM cell migration to the well-105 
understood migratory behavior of mouse skin-resident TRM cells in vivo
16, 17. To this end, mice 106 
harboring fluorescently labeled skin-resident TRM cells were generated by injection of naïve OT-I T cell 107 
antigen receptor (TCR)-transgenic CD8+ T cells, specific for the ovalbumin-derived SIINFEKL peptide 108 
(OVA257-264), that express green fluorescent protein (GFP), into C57BL/6 mice followed by DNA 109 
vaccination on skin of both hindlegs with a plasmid encoding the OVA257–264 epitope (experimental 110 
setup in Fig. 1b). >44 days after induction of a local T cell response, the migration of tissue-resident T 111 
cells was analyzed by in vivo confocal microscopy. Subsequently, skin of the same animals was 112 
harvested, mounted for ex vivo imaging, and analyzed by longitudinal (4 h) confocal the next day. In 113 
vivo GFP+ skin-resident TRM cells displayed the previously described dendritic morphology and 114 
constantly migrated within the tissue with a median speed of 0.49±0.29 μm/min (Fig. 1c, top and 115 
bottom, and Supplementary Video 1). Imaging of ex vivo skin showed that GFP+ skin-resident TRM 116 
cells remained present within the epidermis and largely retained their dendritic shape (median 117 
circularity of 0.38±0.06 and 0.42±0.03 for in vivo and ex vivo skin-resident TRM cells respectively, 118 
whereby a value of 1.0 represents a fully circular morphology; Fig. 1c, top middle and bottom right). 119 
Furthermore, ex vivo skin-resident TRM cells also retained their constitutive migratory behavior, with a 120 
slightly higher median speed of 0.68±0.70 μm/min (Fig. 1c, bottom left and Supplementary Video 2). 121 
Notably, gas exchange in this ex vivo system was crucial to retain physiological skin-resident TRM cell 122 
behavior, as mounting of murine skin in a setup in which gas exchange is prevented resulted in highly 123 
immobile (median speed of 0.08±0.04 μm/min) and circular (median circularity of 0.72±0.01) GFP+ 124 
skin-resident TRM cells (Fig. 1c, top right and bottom, and Supplementary Video 3). Analysis of 125 
migration parameters revealed that ex vivo skin-resident TRM cells displayed a higher motility 126 
coefficient than in vivo TRM cells, as indicated by non-overlapping confidence intervals (Supplementary 127 
Fig. 1a, left). Nonetheless, persistence time and median turning angles were very comparable 128 
(Supplementary Fig. 1a, middle and right). Prior work has demonstrated that intravital imaging of 129 
pigmented skin can induce a local immune response due to death of light-sensitive pigmented skin 130 
cells and subsequent recruitment of neutrophils24, 25, 26. To study whether the observed T cell behavior 131 
could indeed be influenced by death of pigment-positive skin cells, we performed in vivo and ex vivo 132 
confocal imaging of TRM cells in skin of C57BL/6 albino mice. These data demonstrate that the steady-133 
state patrolling behavior of skin-resident TRM cells was independent of the presence of skin 134 
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pigmentation (Supplementary Fig. 1b, top and bottom left and middle, and Supplementary Video 4). In 135 
addition, the typical TRM cell patrolling behavior observed in confocal imaging, was also seen during 136 
multiphoton (MP) imaging of GFP+ OT-I TRM cells in skin of C57BL/6 albino mice (Supplementary Fig. 137 
1b, top and bottom right, and Supplementary Video 5). In further support of the notion that steady 138 
state migration is an intrinsic property of skin-resident TRM cells, mean speeds remained constant over 139 
long-term confocal and MP imaging periods in skin of C57BL/6 black and albino animals 140 
(Supplementary Fig. 1c).  141 
 Having demonstrated that ex vivo skin-resident TRM cells retain their steady state migratory 142 
behavior, we next examined whether these cells could still respond to cognate antigen encounter. To 143 
address this, mice harboring a mixture of red-fluorescent (mTmG) OVA257–264-specific and green-144 
fluorescent (GFP) Herpes simplex virus (HSV) gB498–505-specific skin-resident TRM cells were 145 
generated by vaccination with vectors encoding these epitopes, thereby allowing the subsequent 146 
comparison of the behavior of these two populations during ex vivo recall with one of the two antigens. 147 
After a >60-day rest period, skin tissue was harvested and mounted for ex vivo imaging. Consistent 148 
with the data in Fig. 1c, ex vivo OT-I-mTmG and gBT-GFP skin-resident TRM cells exhibited a dendritic 149 
morphology and continuously crawled within the tissue in steady state (Fig. 1d left and Supplementary 150 
Fig. 1d). However, upon addition of OVA257–264 peptide to the ex vivo medium, OT-I-mTmG cells 151 
rounded up and stalled, with a 4-fold reduction in median speed, whereas gBT-GFP cells remained 152 
dendritic and motile throughout the recording (Fig. 1d, right, Supplementary Fig. 1d and 153 
Supplementary Video 6). Together, these data demonstrate that this ex vivo imaging system 154 
recapitulates key aspects of in vivo TRM cell behavior and can hence be used to study skin-resident 155 
TRM cells in real-time in settings where in vivo imaging is precluded.  156 
 157 
Ex vivo labeling with anti-CD8 nanobody allows visualization and tracking of CD8+ murine skin-158 
resident TRM cells 159 
In order to visualize the behavior of human CD8+ skin-resident TRM cells in situ, it was necessary to 160 
develop a means to label TRM cells ex vivo. To ensure efficient tissue penetration by fluorescently 161 
labeled antibodies in the relatively thick human skin27, we generated ±15 kDa-sized Alexa Fluor-594 162 
(AF594)-labeled nanobodies against both mouse (m) and human (h) CD8 molecules (hereafter 163 
referred to as anti-mCD8 and anti-hCD8 nanobodies, respectively). Subsequently, ex vivo staining of 164 
murine skin harboring CD8+ GFP+ skin-resident TRM cells was utilized to validate the use of these 165 
reagents. Ex vivo imaging of tissue stained with anti-mCD8 nanobody demonstrated successful 166 
labeling of all GFP+ cells within the tissue (Fig. 2a, left), and this signal remained constant over time 167 
(Fig. 2a, top right). In addition, a population of endogenous, non-GFP-transgenic, tissue-resident CD8+ 168 
cells was detected, as revealed by the presence of single AF594-positive cells (indicated with 169 
asterisk). As a control, staining of mouse skin explants with AF594-nanobody reactive with human 170 
CD8 did not result in specific staining (Supplementary Fig. 2a). Staining of ex vivo mouse skin with 171 
anti-mCD8 nanobody did not lead to a substantial change in morphology of CD8+ GFP+ cells (Fig. 2a, 172 
bottom right). Furthermore, nanobody-labeled skin-resident TRM cells retained a continuous crawling 173 
behavior with similar median speeds (0.82±0.58 μm/min, Supplementary Fig. 2b, top left). Analysis of 174 
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migration parameters showed a 1.3-fold decrease in median turning angles following nanobody 175 
labeling, whereas motility coefficient and persistence time were very comparable to non-labeled ex 176 
vivo skin-resident TRM cells, as indicated by overlapping confidence intervals (Supplementary Fig. 2b, 177 
top right and bottom). Interestingly, in the majority of the cells, the highest intensity of CD8 staining 178 
was observed on the lagging end of migrating skin-resident TRM cells (Supplementary Fig. 2c). 179 
Because of the monovalency of the labeled nanobodies, this is not expected to be a consequence of 180 
labeling-induced receptor clustering and may therefore represent a physiological enrichment at this 181 
site.  182 
To understand at which time scales ex vivo culture would affect tissue integrity, we performed 183 
histopathological analysis of ex vivo cultured tissue fixed at different time points after mounting. 184 
Nanobody-labeled ex vivo tissue that was imaged for a 4 h time period one day after mounting showed 185 
only mild degeneration and mild hypertrophic change of the epidermal squamous cells, and overall 186 
skin integrity was maintained (Supplementary Fig. 2d, top). Langerhans cells have been described to 187 
leave tissues under stress conditions28 and, as a second measure for tissue stress, we performed 188 
staining of Langerhans cells in ex vivo tissue that was fixed at various time points after mounting. This 189 
revealed that Langerhans cells remained present ex vivo up to 72 h in culture (Supplementary Table 190 
1). In addition, large numbers of GFP+ skin-resident TRM cells were still observed at this time point 191 
(Supplementary Fig. 2d, bottom). In order to examine whether labeling of TRM cells with anti-mCD8 192 
nanobody would influence their ability to recognize cognate antigen, OVA257–264 peptide was added to 193 
medium of GFP+ OT-I TRM cells harboring ex vivo skin that was labeled with anti-mCD8 nanobody. 194 
After addition of peptide ligand, CD8+ GFP+ AF594+ cells showed a 3.4-fold reduction in median speed 195 
and became highly circular in less than 30 min, indicating response to antigen encounter (Fig. 2b, left 196 
and bottom, and Supplementary Video 7). As a side note, the previously enriched mCD8 signal at the 197 
rear side of patrolling cells appeared redistributed over the cell surface upon antigen delivery (Fig. 2b, 198 
top right). While all GFP+ AF594+ cells stalled after peptide addition, isolated dendritic single positive 199 
AF594+ cells were observed that continued to migrate after OVA257–264 peptide addition, suggesting 200 
that these endogenous cells recognized a distinct epitope. While antigen recognition by TRM cells was 201 
not affected by nanobody labeling in these settings, such labeling could potentially affect TCR 202 
triggering at lower antigen concentrations. Analysis of in vitro cytokine production by anti-mCD8 203 
nanobody-labeled mouse T cells revealed a reduction in antigen sensitivity of approximately 10-fold 204 
(Supplementary Fig. 2e). Notably, staining of human T cells with anti-hCD8 nanobody did not 205 
measurably influence their antigen sensitivity or the recognition of tumor cells that endogenously 206 
expressed the cognate antigen (Supplementary Fig. 3a).  207 
Collectively, these data demonstrate that ex vivo imaging of CD8+ skin-resident TRM cells is 208 
feasible, that these cells retain their physiological tissue patrolling behavior, and that such cells can 209 
efficiently be labeled with nanobodies in situ.  210 
 211 
Migratory behavior of human CD8+ skin-resident TRM cells 212 
Memory T cells have been observed in healthy human skin, with numbers remaining stable up to 90 213 
years of age4. Contrary to T cells present in skin during ongoing infections, T cells present in healthy 214 
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skin tissue are likely to represent resident memory cells as revealed by expression of CD45RO, CLA 215 
and CD6929, 30. To study the behavior of these cells in situ, we mounted punch biopsies of skin 216 
material obtained after abdominoplastic or breast reconstructing surgery for ex vivo imaging and 217 
stained these tissues with anti-hCD8 nanobody. Multiphoton microscopy (MP) the next day revealed 218 
specific staining of CD8+ cells in human skin, as compared to staining with irrelevant anti-mCD8 (Fig. 219 
3a). To investigate the localization of CD8+ cells in human skin samples, tissues were also incubated 220 
with the nuclear dye Hoechst, to show the distribution of all nucleated cells in these samples. This 221 
imaging revealed a subpopulation of CD8+ cells that was preferentially located in the stratum basale of 222 
the epidermis (Fig. 3b, left). In addition, imaging of collagen type I by second harmonic generation 223 
(SHG) signal showed the presence of sizable numbers of CD8+ cells in the papillary dermis (Fig. 3b, 224 
middle and right). To assess whether the observed dermal and epidermal cell populations both 225 
reflected resident memory T cells, we analyzed expression of CD69 and CD103 on CD8+ cells isolated 226 
from the dermal and epidermal layer, revealing CD69 positivity on nearly all CD8+ cells in both 227 
compartments, and with a large fraction of cells also expressing CD103 (Fig. 3c). In addition, this 228 
analysis revealed that the in situ labeling of CD8+ T cells identifies the entire CD8+ T cell compartment 229 
present in these skin biopsies, as determined by co-staining of single cell suspensions of in situ 230 
labeled cells with conventional anti-CD8 antibody following digestion (Supplementary Fig. 3b).  231 
Long term MP imaging of human skin stained with anti-hCD8 revealed that CD8+ TRM cells 232 
migrated in the epidermal and dermal compartment, with speeds remaining constant throughout MP 233 
imaging sessions (Supplementary Video 8 and Supplementary Fig. 3c). Co-staining of ex vivo tissues 234 
with anti-hCD8 and the nuclear dye Hoechst revealed that CD8+ TRM cells in the epidermal 235 
compartment migrated in the stratum basale, through a dense environment of keratinocytes (Fig. 3d 236 
and Supplementary Video 9). In contrast to the CD8+ skin-resident TRM cells observed in mouse 237 
epidermis, human epidermal CD8+ TRM cells did not only migrate primarily in 2D but followed the 3D 238 
structure of the finger-like dermal projections (Fig. 3e and Supplementary Video 10). Migration of 239 
epidermal TRM cells in close proximity to the basement membrane (BM) could likewise be revealed by 240 
co-staining with an antibody for collagen type IV (col-IV) that forms one of the major BM components31 241 
(Fig. 3f and Supplementary Video 10). As only a fraction of human epidermal CD8+ TRM cells also 242 
expresses CD103, we next investigated the location and motility of the CD8+CD103– and CD8+CD103+ 243 
TRM cell subsets. To this end, we co-stained tissue explants with the anti-hCD8 nanobody and an 244 
antibody for hCD103. Real-time imaging of these samples revealed that the CD103– and CD103+ 245 
epidermal CD8+ TRM cell subsets were intermingled and migrated through the tissue, with comparable 246 
speeds (0.54±0.82 and 0.57±0.64 μm/min, respectively). In all double positive epidermal T cells, the 247 
CD103 antibody complex was enriched at the lagging-end of migrating CD8+ TRM cells (Fig. 3g and 248 
Supplementary Video 11). This location may potentially be explained by labeling-induced receptor 249 
clustering, and future studies using different labeling strategies may test this. Ex vivo staining of tissue 250 
with anti-hCD1a antibody also allowed visualization of Langerhans cells. MP imaging showed that 251 
Langerhans cells were located above CD8+ skin-resident TRM cells in the upper layers of the epidermis 252 
pointing their dendritic protrusions upwards (Fig. 3h, left image), and with examples of CD8+ T cells 253 
migrating in close proximity (Fig. 3h, three right images). In contrast to the motility of CD8+ TRM cells in 254 
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human epidermis, Langerhans cells remained sessile throughout these recordings (Supplementary 255 
Video 12).  256 
 The majority of human CD8+ skin-resident TRM cells was found to be located in the dermal 257 
compartment (Fig. 3b), providing the opportunity to also examine migratory behavior of human CD8+ 258 
TRM cells at a second tissue site. To this end, real-time MP imaging sessions (3.5-4 h) of skin tissue 259 
from 4 individuals were performed. Human CD8+ skin-resident TRM cells migrated through the dermis 260 
with median speeds around 0.40±1.09 μm/min (Fig. 4a, left). Compared to murine epidermal CD8+ 261 
skin-resident TRM cells, human dermal CD8
+ T cells showed a larger heterogeneity in speed at the 262 
single cell level. Persistence times and motility coefficients were comparable for murine CD8+ skin-263 
resident TRM cells and human dermal T cells when these were estimated from short-term observation 264 
windows (Fig. 4a, middle and right). However, in contrast to murine CD8+ skin-resident TRM cells, long-265 
term migration of human dermal CD8+ T cells could not be described as a persistent random walk 266 
(Supplementary Fig. 3d). Migration of human dermal CD8+ skin-resident TRM cells was observed in 267 
both collagen type I-dense and -poor areas (Fig. 4b, top image), with a fraction of CD8+ T cells in 268 
collagen type I-poor areas migrating along the perimeter of these structures (Fig. 4b, middle and 269 
bottom images and Supplementary Video 13). Analysis of skin biopsies co-stained with anti-hCD8 270 
nanobody and an antibody for collagen type IV to identify BMs, revealed that these collagen type I-271 
poor regions were frequently filled with dermal vessels such as blood capillaries (Fig. 4c, top), and 272 
real-time imaging of these explants showed examples of dermal CD8+ TRM cells migrating along the 273 
lining of these vessels (Fig. 4c, bottom, and Supplementary Video 14).  274 
To examine whether local presence of collagen type I affects TRM cell migration, we compared 275 
speed-steps of TRM cells at both sites. While the median speeds for cells in collagen type I-dense or -276 
poor areas was highly similar, fast speed steps were significantly more often observed in collagen type 277 
I-poor areas, suggesting that collagen type I forms a barrier for dermal TRM cell migration 278 
(Supplementary Fig. 3e).  279 
Finally, in 3 out of 5 explants analyzed, cases of CD8+ skin-resident TRM cells that migrated in 280 
and out of the dermis, as based on the distance from the nearest collagen type I signal, were 281 
observed (Fig. 4d and Supplementary Video 15). While large data sets are required to understand the 282 
magnitude of this process, these data suggest that TRM cells at the two sites might not be two fully 283 
separate compartments.  284 
Collectively, these data demonstrate that human CD8+ skin-resident TRM cells patrol both the 285 
epidermal and dermal compartment and, using labeling of 3 cell surface markers and one extracellular 286 
protein, show that the ex vivo imaging system that we develop here provides a versatile tool to study 287 
the behavior of skin-resident immune cell populations in real-time.  288 
  289 
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Discussion 290 
To our knowledge, this is the first longitudinal analysis of the behavior of resident memory T cells in 291 
human tissue. To allow this, we established an ex vivo imaging system for the in situ labeling and real-292 
time tracking of CD8+ TRM cells in human skin. Using this approach, we demonstrate that human CD8
+ 293 
cells actively migrate in both the epidermal and dermal layers of the skin, with median speeds in the 294 
same range as those of murine CD8+ skin-resident TRM cells. These CD8
+ cells reflect tissue-resident 295 
memory T cells, as all CD8+ cells isolated from both skin compartments express CD69+, the principal 296 
defining feature of TRM cells
6, 30. These data establish that tissue patrol is a property of human CD8+ 297 
skin-resident TRM cells, and fit with the model that relatively rare CD8
+ TRM cells can act as local 298 
sentinels to provide a rapid and tissue-wide anti-pathogen response20, 21. The observation of TRM cell 299 
patrol in both the dermis and epidermis, two sites with a different tissue architecture, combined with 300 
the notion that tissue patrol has been observed for murine TRM cells in multiple organs
16, 18, 32, makes it 301 
reasonable to postulate that a continuous migratory behavior forms a shared property of all human 302 
CD8+ TRM cell populations. 303 
In the epidermal compartment, human CD8+ TRM cells migrate in the stratum basale in a dense 304 
environment of keratinocytes. The adhesive interactions between epithelial cells and T lymphocytes 305 
includes the binding of E-cadherin to the αE (CD103) β7 integrin that is present on many tissue 306 
resident T cells33. With the caveat that antibody labeling may potentially influence this interaction, in 307 
the current dataset we did not find any evidence for a difference in motility between single positive 308 
CD8+ TRM cells and those that also express CD103.  309 
Consistent with prior data34, the majority of CD8+ T cells in healthy human skin were observed 310 
in the dermal compartment. These cells show a distinct migratory behavior as compared to murine 311 
CD8+ skin-resident TRM cells, with a larger heterogeneity in speed. One explanation for this 312 
heterogeneity is that the dermis comprises different structures that may form barriers to TRM cell 313 
migration. Further evidence for a model that local structure may influence TRM cell migration 314 
parameters comes from the observation that TRM cells in dermal areas with a low collagen type I 315 
density show a higher frequency of fast steps than those in high-density areas. In line with this, the 316 
former areas have been described to contain collagen type III, and connective tissues enriched for this 317 
collagen are described to be more flexible compared to collagen type I dense tissues35, 36. Within 318 
areas with low collagen type I density, examples of TRM cells migrating along the lining of blood 319 
capillaries were observed. Given the strategic positioning of these TRM cells, it may be postulated that 320 
they are located at these sites to patrol epidermal supply routes. Contrary to the notion of epidermal 321 
CD8+ TRM cells as a fully isolated cell compartment that has emerged from mouse model studies, we 322 
also encountered examples of human CD8+ skin-resident TRM cells located at the dermal-epidermal 323 
junction migrating in and out of the dermis. While the BM forms a tight boundary between these two 324 
compartments, the potential for immune cells to cross this barrier through small pores has previously 325 
been suggested by electron microscopy analyses37.  326 
From a technological perspective, the successful ex vivo staining with anti-CD8 nanobodies, 327 
but also with full-size anti-CD1a, anti-collagen type IV and anti-CD103 antibodies, indicates that the 328 
current system may be utilized to study a wide variety of skin molecules and cell types of interest in 329 
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real-time. As in all imaging experiments that use exogenous labels, and as illustrated by the reduction 330 
in antigen sensitivity of mouse but not human T cells upon staining with anti-CD8 nanobodies, it will be 331 
important to understand whether labeling influences cell behavior. In future studies in healthy human 332 
skin it will be interesting to investigate whether the CD4+ CD103– memory T cells that are present at 333 
high density in the dermis29, 30 show a similar patrolling behavior as CD8+ TRM cells, and whether these 334 
cells co-localize with either CD8+ TRM cells or defined antigen-presenting cell populations (APCs). 335 
Finally, whereas the current study focuses on the behavior of tissue-resident T cells in healthy tissue, 336 
this ex vivo technology should also provide a tool to study T cell behavior in the effector and memory 337 
phase of TRM cell-mediated skin conditions
4, 22.  338 
339 
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Fig. 1 | Tissue patrol and cognate antigen recognition by ex vivo murine skin-resident TRM cells. 488 
a, Illustration of ex vivo skin imaging setup. b, Experimental setup to compare in vivo and ex vivo skin-489 
resident TRM cell behavior. c, Top: confocal maximum intensity projections of in vivo (left, overview and 490 
zoomed image), ex vivo air exposed (middle, overview and zoomed image) and ex vivo non air 491 
exposed (right, zoomed image) OT-I-GFP (green) cells. Bottom: in vivo (left, median speed, n=217; 492 
right, circularity, n=342), ex vivo air exposed (left, median speed, n=185; right, circularity, n=364) and 493 
ex vivo non air exposed (left, median speed, n=33; right, circularity, n=31) skin-resident TRM cells. 494 
Black dots represent medians of individual tracks of TRM cells (left) or average TRM cell circularity per 495 
frame (right), red lines indicate median of cell population, FD indicates fold difference. Two-tailed 496 
Mann-Whitney U-tests were performed. In vivo and ex vivo with gas exchange data are representative 497 
of n=3 mice per condition (4 h recordings), ex vivo without gas exchange data are based on n=1 (1 h 498 
recording). d, Confocal maximum intensity projections (overview and zoomed image) of OT-I-mTmG 499 
(red) and gBT-GFP (green) cells before (top left) and after (top right) OVA257-264 addition. Note that, 500 
next to red fluorescent T cells, autofluorescent hair fragments are visible in the red channel. Bottom: 501 
individual tracks of cells in 1 h- (pre) and 2 h- (post) recordings after normalization of starting positions 502 
to the origin. Data are representative of 3 mice. Scale bars indicate 50 μm and 10 μm for overviews 503 
and zoomed images, respectively.  504 
 505 
Fig. 2 | Migration and cognate antigen recognition by in situ nanobody labeled ex vivo CD8+ 506 
skin-resident TRM cells. a, Left: confocal maximum intensity projections (overview and zoomed 507 
images) of skin tissue harboring OT-I-GFP (green) skin-resident TRM cells stained ex vivo with anti-508 
mCD8-AF594+ (red) nanobody. Asterisk indicates endogenous (GFP–) CD8+ cell. Top right: 509 
enumeration of GFP+ AF594+ double positive and AF594+ single positive cells at different time points 510 
after start of the recording. Bar graph shows mean plus SD and individual data points. Bottom right: 511 
circularity of anti-mCD8 nanobody labeled GFP+ cells over time. Data are based on 4h recordings of 512 
n=3 mice. b, Top left: confocal maximum intensity projections of ex vivo anti-mCD8 labeled skin-513 
resident TRM cells, before (top) and after (middle, bottom) OVA257-264 addition. Note that the sole AF594 514 
single positive cell remains dendritic. Top right: illustration of kinetics of morphology change of a GFP+ 515 
AF594+ cell upon ex vivo OVA257-264 addition (time in minutes, peptide addition at t=0). Bottom left: 516 
circularity of GFP+ cells before and after OVA257-264 addition (indicated with dashed red line). Bottom 517 
right: black dots indicate median speeds of individual tracks pre- (n=53) and post- (n=31) antigen 518 
delivery, with red lines indicating median of all cells. FD indicates fold difference. A two-tailed Mann-519 
Whitney U-test was performed. Data are representative of n=2 mice and 2 h recordings. Scale bars 520 
indicate 50 μm and 10 μm for overviews and zoomed images, respectively. Circularity graphs show 521 
min-max (lines), individual data points (dots), and the mean (plus-symbol). 522 
 523 
Fig. 3 | Migratory properties of CD8+ TRM cells in human epidermis. a, Multiphoton (MP) maximum 524 
intensity projections of ex vivo human skin stained with anti-hCD8-AF594 (left and middle, red, 525 
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representative of n=4 individuals)) or control anti-mCD8-AF594 (right, red, representative of n=3 526 
individuals). Scale bars indicate 50 μm and 10 μm for overviews and zoomed images, respectively. 527 
Second harmonics signal (SHG) represents dermal collagen type I (blue). b, Left: virtual sectioning of 528 
MP images of ex vivo anti-hCD8 (red) and Hoechst 33342 (nuclei, grey) stained biopsy (SHG, blue). 529 
‘>’ indicate CD8+ cells and scale bars represent 50 μm. Right: quantification of AF594+ cells in 530 
indicated compartments over time. Data is representative of n=4 individuals. Bar graphs show mean 531 
plus SD and individual data points. c, Flow cytometric analysis of indicated single cell suspensions. 532 
Cells are gated on single/live/CD8+ lymphocytes (n=3 individuals). Right: black symbols indicate 533 
individuals, red line indicates median. d, MP maximum intensity projection of Hoechst+ hCD8+ cell 534 
(grey and red) migrating in between Hoechst+ nuclei (representative of n=4 individuals). e, 3D-surface 535 
rendering of MP recording of epidermal hCD8+ cell (red) migrating on top of dermal papillae (SHG, 536 
blue). f, Orthogonal view of MP recording showing CD8+ (red) cells in close proximity to collagen type 537 
IV positive basement membrane (green) (SHG, blue) (representative of n=3 individuals). g, Left: virtual 538 
sectioning of MP recording (left) and pooled track plots (right) of epidermal CD8+ (red) and 539 
CD8+CD103+ (red + green) cells (SHG, blue) (representative of n=3 individuals). Scale bars in Fig. 3d-540 
g indicate 20 μm. h, Left: virtual sectioning of MP recording of anti-hCD1a (green) plus anti-hCD8 (red) 541 
stained biopsy (SHG, blue). Scale bar indicates 50 μm. Right three images: 3D surface rendering of 542 
CD8+ cell migrating in close proximity to CD1a+ Langerhans cells (representative of n=4 individuals). 543 
Scale bars indicate 10 μm.  544 
 545 
Fig. 4 | Human CD8+ TRM cells patrol the papillary dermis. a, Left: median speeds of individual 546 
tracks (black dots) of dermal CD8+ TRM cells of 4 different individuals indicated with I (n=96), II (n=52), 547 
III (n=21) and IV (n=49) (3.5-4 h-recordings). Red bar indicates median. Middle and right: estimated 548 
motility coefficient (middle) and persistence time (right) with error bars indicating 95% confidence 549 
interval (the range q0.025-q0.975) based on bootstrapping of the data (black dots indicate median). 550 
Murine data is based on n=3 (4 h recordings) and human data on n=4 (3.5-4 h recordings). b, Virtual 551 
sectioning showing an MP maximum intensity of a hCD8+ (red) cell migrating along the perimeter of a 552 
collagen type I (SHG)-poor area. Scale bars indicate 20 μm. c, Top left: Perspective top view of MP 553 
recording of anti-hCD8 (red) and anti-collagen type IV (green) stained biopsy (SHG, blue) (scale bar: 554 
50 μm). Top middle, right: section view of CD8+ cell located adjacent to a basement membrane 555 
positive vessel (scale bar: 15 μm). Note that collagen type I-poor areas (indicated with dashed white 556 
line) are filled with dermal vessels. Bottom: bottom view of 3D surface rendering of hCD8+ (red) cell 557 
migrating along collagen type IV positive (green) dermal vessel (time in minutes). Data are 558 
representative of n=3 individuals. d, 3D-surface rendering with blend-shading of dermal collagen type I 559 
(SHG, blue) and a CD8+ cell (red) migrating on top of dermal papillae and moving into the dermis 560 
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C57BL/6j-Ly5.1 (referred to in the text as C57BL/6j mice), C57BL/6j OT-I, C57BL/6j mT/mG, and 567 
C57BL/6j UCB-GFP transgenic mice were obtained from Jackson Laboratories, the C57BL/6JRjAlbino 568 
strain was obtained from Janvier labs. C57BL/6j gBT I.1 TCR transgenic mice were a kind gift from F. 569 
Carbone (Doherty Institute, Australia). All animals were maintained and crossed in the animal 570 
department of The Netherlands Cancer Institute (NKI). All animal experiments were approved by the 571 
Animal Welfare Committee of the NKI, in accordance with national guidelines.  572 
 573 
Adoptive transfer, DNA vaccination 574 
CD8+ T cells were obtained from single-cell suspensions of spleens from OT-I-GFP, gBT-GFP, or OT-575 
I-mTmG mice using the mouse CD8+ T lymphocyte enrichment kit (BD Biosciences). Mice received a 576 
total of 2 × 105 CD8+ cells intravenously in the tail vein. DNA vaccination was performed on depilated 577 
hind legs of anesthetized mice by application of plasmid DNA encoding TTFC-OVA257–264 (SIINFEKL), 578 
or a mix of TTFC-OVA257–264 (SIINFEKL) and TTFC-gB498–505 (SSIEFARL) (3 rounds of vaccination, 579 
using 60 μg of DNA per vaccination38, 39), by means of a sterile disposable 9-needle bar mounted on a 580 
rotary tattoo device (MT.DERM GmbH).  581 
 582 
Generation of fluorescently labeled nanobodies  583 
Escherichia coli cells were transformed with the expression vector pHEN6 encoding either the anti-584 
mouse CD8 nanobody 118, or the anti-human CD8 nanobody 218, followed by an LPETGG-6xHis 585 
sequence. Bacteria were grown to OD 0.6-0.8 at 37°C and protein production was induced with 1 mM 586 
IPTG, overnight at 30°C. Cells were harvested, resuspended in 1x TES buffer (200 mM Tris, pH 8, 587 
0.65 mM EDTA, 0.5 M sucrose) and incubated at 4°C for 1 h. Subsequently, cells were exposed to 588 
osmotic shock by 1:4 dilution in 0.25X TES buffer, overnight at 4°C, and the periplasmic fraction was 589 
isolated by centrifugation and loaded onto Ni-NTA beads (Qiagen) in 50 mM Tris, pH 8, 150 mM NaCl 590 
and 10 mM imidazole. Protein was eluted in 50 mM Tris, pH 8, 150 mM NaCl, 500 mM imidazole, was 591 
then loaded onto a Biosep 3000 Phenomenex gel filtration column running in phosphate-buffered 592 
saline (PBS), and the appropriate fractions were collected. Purity of recombinant nanobody was 593 
assessed by SDS/PAGE analysis, and material was concentrated using an Amicon 10,000 kDa 594 
MWCO filtration unit (Millipore), and stored at -80°C. To generate the fluorescent label, 1mg of Alexa 595 
Fluor-594 (AF594) maleimide dye (Thermo Fisher Scientific) was ligated to 200 μM GGGC peptide in 596 
the presence of 10 mM NaHCO3 and was then purified on a C5 column (Waters). In order to 597 
covalently link the fluorescent label to the nanobody, sortase reactions were performed. To this end, 598 
purified GGGC-AF594 (80 μM) was incubated with purified nanobody-LPETGG-6xHis (5 μM) and 599 
penta- (5M) or hepta- (7M) mutant sortase (0.8 μM) for 2 h at 4°C in 10 mM CaCl2, 50 mM Tris pH 8 600 
and 150 mM NaCl (sortase was produced in-house according to a previously described protocol using 601 
sonification instead of French press40). Sortase and unreacted nanobody were removed by adsorption 602 
onto Ni-NTA agarose beads (Qiagen). Subsequently, the unbound fraction was added on top of a 100 603 
kDa cut-off filter to remove Ni-NTA agarose beads, flow-through was concentrated, and unconjugated 604 
GGGC-AF594 was removed using an Amicon 10,000 kDa MWCO filtration unit (Millipore) by 605 
exchanging the protein solution three times with PBS. The material was further purified using a zeba 606 
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spin column (Thermo Fisher Scientific). Resulting anti-mouse and anti-human CD8-AF594 nanobody 607 
conjugates were stored in aliquots at -20°C. Protein concentrations were determined using nanodrop 608 
and individual batches of labeled nanobody were titrated for optimal usage (final concentrations 609 
ranging from 5-10 μg/ml).  610 
 611 
Functional analysis of anti-mCD8 nanobody labeled murine T cells in vitro  612 
For functional analysis of anti-mCD8 nanobody stained murine T cells in vitro, first a spleen of a 613 
C57BL/6j OT-I mouse was mashed and resuspended in RPMI (Thermo Fisher Scientific), fetal calf 614 
serum (8% final, Sigma-Aldrich), penicillin streptomycin (100 U/ml) and L-glutamine, supplemented 615 
with 50 μM beta-mercaptoethanol, non-essential amino acids, 1 mM sodium pyruvate and 10 mM 616 
HEPES (all Thermo Fisher Scientific) and plated in 96-well tissue-treated plates. Cells were then 617 
labeled with anti-mCD8-AF594 or anti-hCD8-AF594 nanobody in the same concentration as used for 618 
peptide stimulation experiments in ex vivo murine tissue material (5 μg/ml final) for 4 h, washed twice, 619 
and subsequently stimulated overnight with indicated amounts of OVA257-264 peptide. After 14-18 h, 620 
cells were washed twice and stained with anti-mCD8-beta-PeCy7 (eBioH35-17.2, eBioscience), anti-621 
mouse TCR V beta 5.1/5.2-APC (MR9-4, Thermo Fisher Scientific), anti-mCD25-BV650 (PC61, 622 
BioLegend), anti-mCD69-APC-Cy7 (H1.2F3, BioLegend) and 4',6-Diamidino-2-Phenylindole, 623 
Dihydrochloride (DAPI) (Sigma-Aldrich) to exclude dead cells, and samples were measured on an 624 
LSR II SORP (BD Biosciences). Cells were analyzed according to the gating strategy shown in 625 
Supplementary Fig. 4a. 626 
 627 
Functional analysis of anti-hCD8 nanobody labeled human T cells in vitro  628 
For functional analysis of anti-hCD8 nanobody stained human T cells in vitro, we used T cells 629 
transduced with two TCRs that recognize a CDK4-derived neoantigen with different affinities (41 and 630 
unpublished). In brief, T cells were plated in 96-well tissue-treated plates in RPMI (Thermo Fisher 631 
Scientific), human serum (8% final, Sigma-Aldrich) and penicillin streptomycin (100 U/ml) (Thermo 632 
Fisher Scientific) and labeled with anti-mCD8-AF594 or anti-hCD8-AF594 nanobody in the same 633 
concentration as used for ex vivo imaging of human tissue material (5 μg/ml final) for 4 h. Cells were 634 
then washed twice and co-cultured overnight with JY cells (American Type Culture Collection (ATCC) 635 
loaded with the indicated concentrations of CDK4mut peptide (ALDPHSGHFV
41), or with the CDK4wt 636 
cell line MM90904 (a kind gift from M. Donia, Herlev Hospital, Denmark) or the CDK4mut cell line 637 
NKIRTIL00642 at a 1:1 ratio. After 14-18 h incubation, cells were washed twice and stained with anti-638 
hCD8a-PerCP-Cy5.5 (SK1, BioLegend), anti-mouse TCR beta-AF488 (H57-597, BioLegend) to detect 639 
the TCR-modified cells41, anti-hCD137-BV421 (4B4-1, BioLegend) and IR-dye (Thermo Fisher 640 
Scientific) to exclude dead cells, and samples were measured on an LSR II SORP (BD Biosciences). 641 
Cells were analyzed according to the gating strategy shown in Supplementary Fig. 4b. 642 
 643 
Ex vivo preparation, ex vivo labeling, and ex vivo peptide stimulation of mouse tissue 644 
Skin tissue of depilated hind legs of sacrificed mice was obtained using forceps and cleared of 645 
connective tissue and fat. Skin pieces were mounted in ex vivo Lumox 35-mm dishes (for adherent 646 
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cells, Sarstedt), with the epidermis facing downwards to the gas-permeable bottom. For analysis of a 647 
non-air exposed setup, a 35-mm glass-bottom Willco dish was utilized (WillCo wells). A gas-648 
permeable film (8 μm pores, 25-mm diameter, Sigma-Aldrich) was placed on top of the dermal side of 649 
the skin, followed by a layer of LDEV-Free reduced growth factor basement membrane matrix matrigel 650 
(Geltrex, Invitrogen) and culture medium consisting of Opti-MEM (Thermo Fisher Scientific), fetal calf 651 
serum (8% final, Sigma-Aldrich), penicillin streptomycin (100 U/ml) and L-glutamine (both Thermo 652 
Fisher Scientific). When imaging ex vivo tissue directly after harvest and mounting, skin-resident TRM 653 
cells exhibited a higher circularity and were relatively immobile, but cells regained motility and 654 
dendricity overnight (data not shown). Histopathological analysis showed that skin conditions 655 
deteriorate over time, with mild alterations in the first 24 h but signs of severe skin degeneration 656 
apparent at 72 h (Supplementary Fig. 2d, top). For these reasons, all ex vivo experiments were 657 
performed after an overnight recovery period, but no later than 24 h after mounting. For ex vivo 658 
labeling, skin samples were incubated with anti-mouse or anti-human CD8-AF594 nanobodies 659 
overnight at 37°C and 5% CO2 and washed 2 times before imaging. For peptide stimulations, OVA257–660 
264 peptide was added to the ex vivo culture medium (80 nM final concentration) and imaging was 661 
performed immediately thereafter.  662 
 663 
In vivo and ex vivo mouse skin imaging  664 
Isoflurane anesthetized mice with depilated areas of the hind legs were placed in a custom-built 665 
chamber with the skin placed against a coverslip at the bottom side of the chamber. In case of imaging 666 
of ex vivo skin tissue, the dish with mounted tissue was placed in an inlay, with the epidermal side 667 
facing downwards. The lid of the dish was removed and the dish was covered with gas permeable 668 
CultFoil to prevent evaporation (Pecon), topped by a custom-built cover connected to a CO2-flow. 669 
Images were acquired using an inverted Leica TCS SP5 confocal scanning microscope equipped with 670 
diode and Argon lasers and enclosed in a custom-built environmental chamber that was maintained at 671 
37°C using heated air. Images were acquired using a 20×/0.7 N.A. dry objective. GFP was excited at 672 
488 nm wavelength and collected between 498-550 nm. To visualize AF594 signal, the sample was 673 
excited at 594 nm and signal was detected between 604-700 nm. For imaging of mTmG+ cells, 561 674 
nm was used to excite tissue and signal was collected at 571-700 nm. Three-dimensional z-stacks 675 
(typical size 388 μm × 388 μm × 23 μm; typical voxel size 0.8 μm × 0.8 μm × 1.0 μm) were captured 676 
every 2 min for a period of up to 4 h.  677 
 678 
Histopathology and immunohistochemistry 679 
For histopathological analyses, 2 μm thick formalin-fixed, paraffin-embedded full-thickness murine 680 
tissue slides were stained with hematoxylin-eosin. Immunohistochemical analysis was performed on 4 681 
μm thick serially cut slides stained with anti-GFP (ab6556, Abcam) or anti-Langerin (CD207, 682 
eBioRMUL.2, eBioscience) antibodies. Antibody staining was revealed with 3,3′-diaminobenzidine 683 
(Sigma). Slides were evaluated and scored by an animal pathologist blinded to experimental 684 
conditions.  685 
 686 
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Ex vivo imaging of human skin  687 
Punch biopsies (5 mm) were taken from resected normal human skin tissue directly after 688 
abdominoplastic- or breast reconstructing surgery, obtained in accordance with national ethical 689 
guidelines. Skin was cleared of fat and connective tissue and mounted as described in Fig. 1a. For ex 690 
vivo labeling, samples were incubated with anti-mouse or anti-human CD8-AF594 nanobody, Hoechst 691 
33342 (5-10 μg/ml final concentration, Thermo Fisher Scientific), anti-human-CD1a-AF488 antibody 692 
(4-8 μg/ml final concentration, HI149, BioLegend), anti-human-collagen type IV-AF488 antibody (6.25-693 
12.5 μg/ml final concentration, 1042, Thermo Fisher Scientific) or anti-human-CD103-AF488 694 
(concentrated on a 100 kDa cut-off Amicon spin column (Millipore) and resuspended in PBS to remove 695 
sodium azide, used in 5-10 μg/ml final, Ber-ACT8, BioLegend) overnight at 37°C and 5% CO2, as 696 
indicated. Antibodies were titrated per individual, to accommodate variability in skin thickness and 697 
permeability. For subsequent multiphoton (MP) imaging, ex vivo culture dishes were washed 2 times 698 
and topped with ex vivo culture medium (as described in ‘Ex vivo preparation, ex vivo labeling, and ex 699 
vivo peptide stimulation of mouse tissue’ of the ‘Materials and Methods’-section), enclosed with 700 
parafilm and placed under an upright Leica SP8 system equipped with a Spectraphysics Insight 701 
Deepsee laser. Images were acquired with a 25x/0.95 N.A. water immersion objective (Leica Fluotar 702 
VISIR), two NDD HyD detectors and an 8,000-Hz resonant scanner in a custom-built environmental 703 
chamber that was maintained at 37°C using heated air supplemented with 5% CO2. For detection of 704 
AF594 and AF488, wavelength was tuned to 800 nm and collected at a 615/30 and 525/50 band pass 705 
filters (bp), respectively. For detection of the second harmonics signal (SHG), wavelength was tuned 706 
to 1050 nm and collected at 525/50bp. For detection of Hoechst signal, laser was tuned to 800 nm and 707 
collected at 450/65bp. Three-dimensional stacks (typical size 591 μm × 591 μm × 130 μm; typical 708 
voxel size 0.6 μm × 0.6 μm × 1.0 μm) were captured every 3 min for periods of up to 4 h. For 709 
identification of basement membrane-positive structures as blood capillaries, anti-collagen type IV 710 
staining was scored by two independent pathologists. Provided that the human skin sample was 711 
imaged within the pre-determined 24 h time window and stained with optimally titrated 712 
antibodies, motile CD8+ T cells could be observed in all samples (n=18 donors), with cells having a 713 
large heterogeneity in cell speed. Note that Hoechst dye must be titrated carefully, as excess amounts 714 
reduce CD8+ T cell mobility.  715 
 716 
Flow cytometry of human skin samples 717 
For analysis of human skin-resident TRM cells by flow cytometry, fresh full-thickness human skin was 718 
kept at 4°C overnight and 0.4 mm sheets were prepared by a dermatome the next morning. 719 
Subsequently, epidermis and dermis were separated after a 2 h incubation with dispase (0.2% wt/vol, 720 
Sigma-Aldrich) at 37°C. Epidermis was further digested using Trypsin-EDTA (0.05% final, Thermo 721 
Fisher Scientific), for 30 min at 37°C. Single-cell suspensions of the dermis were obtained by 722 
incubation with collagenase type I (0.2% final, Invitrogen) and DNase (30 IU/ml, Sigma) under 723 
continuous agitation for 2 h at 37°C. Single cell suspensions were cultured overnight in low-dose 724 
human recombinant-IL-2 (30 IU/ml, Novartis) in RPMI (Thermo Fisher Scientific), fetal calf serum (8% 725 
final, Sigma-Aldrich), penicillin streptomycin (100 U/ml) and L-glutamine (both Thermo Fisher 726 
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Scientific). Cells were subsequently stained with anti-CD8-BB700 (HIT8a, BD Biosciences), anti-727 
CD69-BV421 (FN50, BioLegend), and anti-CD103-PE (Ber-ACT8, BioLegend). Single cell 728 
suspensions of MP-imaged biopsies were counterstained with anti-CD8-PerCP-Cy5.5 (SK1, 729 
BioLegend). Dead cells were excluded using near-IR-dye (Thermo Fisher Scientific). Flow cytometry 730 
data were acquired using an LSR II SORP (BD Biosciences). Cells were analyzed according to the 731 
gating strategy shown in Supplementary Fig. 4c. 732 
 733 
Data analysis 734 
For image analysis, raw data (murine recordings) or Gaussian filtered data (automatically determined 735 
radius, human recordings) was processed with Imaris (Bitplane). To improve visualization of objects 736 
located deep in human skin tissues, an attenuation correction was performed, as determined by a 737 
correction factor measured on the AF594 channel intensity in ‘slice’ viewer. In order to track 738 
fluorescent objects, the Imaris Spots module was used to calculate cell coordinates (mean positions) 739 
over time. In the subsequent analyses, performed in R (freely available at www.r-project.org) and in 740 
Perl (freely available at www.perl.org), cellular mean positions within a 10 μm distance from the lateral 741 
image borders were discarded, as these would slightly bias the results (e.g., underestimate the 742 
speeds)43. Tissue drift was corrected by tracking mean positions of stationary reference points 743 
resulting from autofluorescence and/or second harmonics signal and by using the shift in these 744 
stationary points to correct the cellular movement. For the analysis to determine the effect of prior 745 
imaging time on speed, 2D speeds were calculated based on cell coordinates in a step-based 746 
manner43, i.e., migration steps were treated independent of the track they originated from. The large 747 
majority of recordings (>91.3%) showed a TRM cell migration speed that was approximately stable over 748 
time; in one case a gradual decrease and in one case a decay in speed at later time points was 749 
observed, likely indicative of a general decrease in cell viability in these samples. For this reason, the 750 
data from the time frames with a decay in speed were not utilized. To determine migration on a per cell 751 
basis, 2D speeds were calculated based on cell coordinates and medians were calculated per cell. 752 
Turning angles between consecutive movement steps were determined by calculating the angle 753 
between vectors representing these steps, and medians were calculated per cell. For both speeds and 754 
turning angles on a per cell basis only tracks with a minimum of 5 time points were incorporated. 755 
Motility coefficients and persistence times were estimated from mean square displacement (MSD) 756 
plots by fitting Fürth’s equation44 for a persistent random walk, i.e., x2 = 2nM (t – Pt(1-e
-t/P
t)), where x
2 is 757 
the mean square displacement, n is the dimension of the space, M is the motility coefficient, Pt is the 758 
persistence time, and t is the elapsed time period since the start of the trajectory. To quantify the 759 
average motility behavior across multiple replicates, a 95% confidence interval (CI) was calculated 760 
based on bootstrapping of tracks from actually observed tracks. To this purpose, artificial instances of 761 
replicates were generated by first randomly selecting the same number of tracks from a replicate as in 762 
the original replicates (with replacement). Subsequently, a weighted average of these tracks was 763 
determined, where the weight was based on the number of intervals occurring within each track. For 764 
instance, a track that is observed during 10 subsequent time points contributes 4 times to the 765 
observation of a time window of length 5, whereas a track observed during 14 subsequent time points 766 
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contributes 8 times to this time window, thus the latter obtains a 2-fold higher weight in the calculation. 767 
The 95% CI for M and Pt was determined based on 1,000 instances of such artificially generated 768 
replicates. In order to compare motility parameters of human versus mouse skin-resident TRM cells, we 769 
fitted the data on the first 15 min of the MSD because the human migration data do not conform to the 770 
pattern expected for persistent random walkers on long time intervals.  771 
To investigate the relationship between local collagen type I (SHG) signal and dermal CD8+ 772 
TRM cell speed, a 3D-surface was created on SHG signal (Gaussian smoothing factor, filter width: 0.75 773 
μm) and segmented into a binary signal (Imaris). Step-based speeds were then calculated for the 774 
tracks based on their 3D distance to the nearest SHG-positive voxel, i.e., steps starting at a maximum 775 
distance of 1 μm from an SHG voxel were classified as being inside collagen type I (‘SHG+’) and those 776 
at a larger distance as being outside collagen type I (‘SHG–’). Distributions of artificial replicates were 777 
generated by randomly sampling an equal number of observations from the SHG+ and SHG– steps, as 778 
in the original data (with replacement). The 95% CI for the 0.75 quantile was determined based on 779 
1,000 replicate instances.  780 
For visual clarity of the MP maximal projections in Fig. 3a and Supplementary Video 8 and 11, 781 
the autofluorescent layer at the top of the epidermal side (observed in all samples in all channels) was 782 
removed using the ‘surfaces’ and ‘mask’ functions in Imaris. To reduce noise in the overview images in 783 
Fig. 3a and Fig. 3g and Supplementary Video 11, a median filter was applied (1-pixel radius). Bleed 784 
through of AF488 into the SHG and AF594 channel was corrected in Supplementary Video 14-I and 785 
15-III by a spillover-factor determined by intensity measurements in the Imaris ‘slice viewer’. For the 786 
quantification of human CD8+ T cells in the epidermal and dermal skin compartments, the position of 787 
AF594+ objects relative to collagen type I (SHG) was determined in the ‘section-’ and ‘slice viewer’, 788 
where cells located above the SHG signal were categorized as epidermal, whereas cells located 789 
below the start of the SHG signal were allocated to the dermal compartment. Human dermal CD8+ 790 
skin-resident TRM cells were defined as tracks located below the start of the SHG signal for the entire 791 
duration of the recording.  792 
Circularity of GFP+ murine skin-resident TRM cells was assessed using an in-house developed 793 
macro in Fiji45. In short, recordings were first filtered by a 3D median filter (0.5-pixels radius) to reduce 794 
noise, after which maximum intensity projections were created. Cells were then segmented using 795 
automatic thresholding (RenyiEntropy) for each frame. Circularity is measured as 4πA/P2 (where A is 796 
the projected (2D) cell area and P is the 1D cell perimeter). 797 
For flow cytometry experiments, data was analyzed using FlowJo (Tree Star). Graphs were 798 
made in GraphPad Prism (GraphPad Software) or in R.  799 
 800 
Code availability 801 
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Statistical analyses were performed in Prism (GraphPad), two-tailed Mann-Whitney U-tests were used 806 
with results being regarded as statistically significant at a P-value of <0.05. 807 
 808 
Life Sciences Reporting Summary 809 
Further information on research design is available in the Nature Research Reporting Summary linked 810 
to this article. 811 
 812 
Data availability 813 
Publicly available source data were not used in this study. Data supporting the findings of this study 814 
are available from the corresponding author upon reasonable request. 815 
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